High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$1.8M
$1,785,488
Total Sells (Filtered)
$0
$0
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| TLSI |
TriSalus Life Sciences, Inc.
|
CEO
Discretionary Buy
|
2026-02-23 | $124,997 | P | Form 4 |
|
TLSI
P
TriSalus Life Sciences, Inc.
Stansky Michael P
• Director
Discretionary BuyΔOwn +44.9%
2026-02-23
$999,990
|
||||||
| TLSI |
TriSalus Life Sciences, Inc.
|
Director
Discretionary BuyΔOwn +44.9%
|
2026-02-23 | $999,990 | P | Form 4 |
|
TLSI
P
TriSalus Life Sciences, Inc.
Stansky Michael P
• Director
Discretionary BuyΔOwn +142.1%
2026-02-23
$480,512
|
||||||
| TLSI |
TriSalus Life Sciences, Inc.
|
Director
Discretionary BuyΔOwn +142.1%
|
2026-02-23 | $480,512 | P | Form 4 |
| TLSI |
TriSalus Life Sciences, Inc.
|
Director
Discretionary Buy
|
2026-02-23 | $40,000 | P | Form 4 |
| TLSI |
TriSalus Life Sciences, Inc.
|
Director
Discretionary Buy
|
2026-02-23 | $124,997 | P | Form 4 |
| TLSI |
TriSalus Life Sciences, Inc.
|
CFO
Discretionary Buy
|
2026-02-23 | $14,994 | P | Form 4 |